{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:49:36Z","timestamp":1762955376268},"reference-count":124,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:00:00Z","timestamp":1424304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.medcli.2014.09.013","type":"journal-article","created":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T07:03:31Z","timestamp":1417071811000},"page":"331.e1-331.e13","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Gu\u00eda diagn\u00f3stica y terap\u00e9utica de las microangiopat\u00edas tromb\u00f3ticas del Grupo Espa\u00f1ol de Af\u00e9resis"],"prefix":"10.1016","volume":"144","author":[{"given":"Enric","family":"Contreras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"de la Rubia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"del R\u00edo-Garma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maribel","family":"D\u00edaz-Ricart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Garc\u00eda-Gala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2014.09.013_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archinte.1925.00120130092009","article-title":"An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries; an undescribed disease","volume":"36","author":"Moschcowitz","year":"1925","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medcli.2014.09.013_bib0010","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1182\/blood-2014-02-555805","article-title":"New anti-complement drugs: Not so far away","volume":"123","author":"Thurman","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0015","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","article-title":"The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: All patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency","volume":"3","author":"Terrell","year":"2005","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: Correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully","year":"2008","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","article-title":"Registry of 919 patients with thrombotic microangiopathies across Japan: Database of Nara Medical University during 1998-2008","volume":"49","author":"Fujimura","year":"2010","journal-title":"Intern Med."},{"key":"10.1016\/j.medcli.2014.09.013_bib0030","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non-enteropathic hemolytic uremic syndrome: Causes and short-term course","volume":"43","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.medcli.2014.09.013_bib0035","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0040","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0045","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.medcli.2014.09.013_bib0050","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2014.09.013_bib0055","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI112736","article-title":"Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation","volume":"78","author":"Moake","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.medcli.2014.09.013_bib0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C","article-title":"Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura","volume":"13","author":"Cohen","year":"1998","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.medcli.2014.09.013_bib0065","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0070","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.3324\/haematol.2013.100685","article-title":"Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura","volume":"99","author":"Grillberger","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2014.09.013_bib0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-0032-1306431","article-title":"Autoimmune thrombotic microangiopathy: Advances in pathogenesis, diagnosis, and management","volume":"38","author":"Tsai","year":"2012","journal-title":"Semin Thromb Hemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0080","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1538-7836.2010.03772.x","article-title":"HLA-DRB1*11: A strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians","volume":"8","author":"Coppo","year":"2010","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0085","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1182\/blood-2012-09-456780","article-title":"Preferential HLA-DRB1*11-dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells","volume":"121","author":"Sorvillo","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0090","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/01.ASN.0000138547.51867.43","article-title":"Verotoxin (shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: Possible implications for the hemolytic uremic syndrome","volume":"15","author":"Bitzan","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.2010.08295.x","article-title":"Advances in understanding the aetiology of atypical haemolytic uraemic syndrome","volume":"150","author":"S\u00e1nchez-Corral","year":"2010","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0100","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2014.09.013_bib0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1182\/asheducation-2013.1.292","article-title":"Thrombotic thrombocytopenic purpura: Basic pathophysiology and therapeutic strategies","volume":"2013","author":"Crawley","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"10.1016\/j.medcli.2014.09.013_bib0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/asheducation-2011.1.15","article-title":"Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations","volume":"2011","author":"Kavanagh","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"10.1016\/j.medcli.2014.09.013_bib0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine"},{"key":"10.1016\/j.medcli.2014.09.013_bib0120","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00277-009-0707-9","article-title":"Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: A comparison of presenting clinical characteristics and response to treatment","volume":"88","author":"Alvarez-Larr\u00e1n","year":"2009","journal-title":"Ann Hematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1537-2995.2007.01534.x","article-title":"Clinical cardiac involvement in thrombotic thrombocytopenic purpura: A systematic review","volume":"48","author":"Hawkins","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.medcli.2014.09.013_bib0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/clc.20731","article-title":"Cardiovascular manifestations in patients with thrombotic thrombocytopenic purpura: A single-center experience","volume":"33","author":"Gandhi","year":"2010","journal-title":"Clin Cardiol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.21881","article-title":"Evidence of persistent neurologic injury following thrombotic thrombocytopenic purpura","volume":"86","author":"Cataland","year":"2011","journal-title":"Am J Hematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MBC.0b013e32833679cb","article-title":"Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: Clinical management and the use of ADAMTS 13 assays","volume":"21","author":"McDonald","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.medcli.2014.09.013_bib0145","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/pbc.24612","article-title":"Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: Comparison of incidence, demographic and clinical features","volume":"60","author":"Reese","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.medcli.2014.09.013_bib0150","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2012-01-403113","article-title":"Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura","volume":"120","author":"Lotta","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-0034-1376152","article-title":"Inherited thrombotic thrombocytopenic purpura in children","volume":"40","author":"Hassenpflug","year":"2014","journal-title":"Semin Thromb Hemost."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2014.09.013_bib0160","first-page":"s153","article-title":"A first bout of thrombotic thrombocytopenic purpura triggered by herpes simplex infection in a 45-year-old nulliparous female with Upshaw-Schulman syndrome","volume":"12","author":"Morioka","year":"2014","journal-title":"Blood Transfus."},{"key":"10.1016\/j.medcli.2014.09.013_bib0165","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00281-014-0416-x","article-title":"Hemolytic uremic syndrome","volume":"36","author":"Mele","year":"2014","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0170","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2014.09.013_bib0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5527\/wjn.v2.i3.56","article-title":"Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations","volume":"2","author":"Salvadori","year":"2013","journal-title":"World J Nephrol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0180","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0185","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2012.09.006","article-title":"Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome","volume":"126","author":"Tsai","year":"2013","journal-title":"Am J Med."},{"key":"10.1016\/j.medcli.2014.09.013_bib0190","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am J Transplant."},{"key":"10.1016\/j.medcli.2014.09.013_bib0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0032-1333538","article-title":"Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia","volume":"39","author":"George","year":"2013","journal-title":"Semin Thromb Hemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0200","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/bjh.12718","article-title":"How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome","volume":"164","author":"Scully","year":"2014","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0205","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","article-title":"Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: Outcome with eculizumab","volume":"29","author":"Delmas","year":"2014","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.medcli.2014.09.013_bib0210","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/qjmed\/hct142","article-title":"Hemolysis and schistocytosis in the emergency department: Consider pseudothrombotic microangiopathy related to vitamin B12 deficiency","volume":"106","author":"No\u00ebl","year":"2013","journal-title":"QJM."},{"key":"10.1016\/j.medcli.2014.09.013_bib0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2013.08.031","article-title":"Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency","volume":"63","author":"Cornec-Le Gall","year":"2014","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.medcli.2014.09.013_bib0220","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2141.1998.01080.x","article-title":"Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group","volume":"103","author":"Rock","year":"1998","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0225","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajh.10450","article-title":"Morphologic diagnosis of thrombotic thrombocytopenic purpura","volume":"75","author":"Burns","year":"2004","journal-title":"Am J Hematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1751-553X.2011.01380.x","article-title":"ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes","volume":"34","author":"Zini","year":"2012","journal-title":"Int J Lab Hematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0240","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/asheducation.V2012.1.604.3798564","article-title":"Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes","volume":"2012","author":"George","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"10.1016\/j.medcli.2014.09.013_bib0245","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiates aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0250","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ndt\/gfp527","article-title":"Acute antibody-mediated rejection after ABO-incompatible kidney transplantation treated successfully with antigen-specific immunoadsorption","volume":"25","author":"Just","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.medcli.2014.09.013_bib0255","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2014.09.013_bib0260","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1055\/s-0037-1614780","article-title":"Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)","volume":"82","author":"Gerritsen","year":"1999","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0265","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00277-002-0502-3","article-title":"Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13)","volume":"81","author":"Bohm","year":"2002","journal-title":"Ann Hematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0270","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1538-7836.2004.00601.x","article-title":"ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate","volume":"2","author":"Whitelock","year":"2004","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0275","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1160\/TH03-11-0675","article-title":"An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations","volume":"91","author":"Zhou","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.medcli.2014.09.013_bib0280","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.medcli.2014.09.013_bib0285","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0290","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.2004.05217.x","article-title":"Von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura","volume":"127","author":"Peyvandi","year":"2004","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0295","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.11739","article-title":"ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission","volume":"93","author":"Peyvandi","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2014.09.013_bib0300","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2014.09.013_bib0305","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2004-11-4490","article-title":"ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases","volume":"106","author":"Rieger","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0310","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2014.09.013_bib0315","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/JCM.28.3.540-545.1990","article-title":"Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction","volume":"28","author":"Pollard","year":"1990","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0320","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/IAI.63.3.1055-1061.1995","article-title":"Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933","volume":"63","author":"Schmidt","year":"1995","journal-title":"Infect Immun."},{"key":"10.1016\/j.medcli.2014.09.013_bib0325","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0330","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2014.09.013_bib0335","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher."},{"key":"10.1016\/j.medcli.2014.09.013_bib0340","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0345","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jemermed.2012.01.027","article-title":"Thrombotic thrombocytopenic purpura: A hematological emergency","volume":"43","author":"Kessler","year":"2012","journal-title":"J Emerg Med."},{"key":"10.1016\/j.medcli.2014.09.013_bib0350","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1537-2995.2007.01530.x","article-title":"Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: The experience of the Oklahoma Registry, 1989 through 2006","volume":"48","author":"Nguyen","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.medcli.2014.09.013_bib0355","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1537-2995.2007.01074.x","article-title":"Comparison and stability of ADAMTS13 activity in therapeutic plasma products","volume":"47","author":"Scott","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.medcli.2014.09.013_bib0360","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.1996.d01-1800.x","article-title":"Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura","volume":"94","author":"Rock","year":"1996","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0365","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1537-2995.2005.00674.x","article-title":"The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: Reconsideration of treatment with cryopoor plasma","volume":"46","author":"Raife","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.medcli.2014.09.013_bib0370","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2008.07292.x","article-title":"Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: A multicentric, prospective cohort study","volume":"143","author":"Del R\u00edo-Garma","year":"2008","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0375","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tmrv.2013.08.001","article-title":"Plasma treated with methylene blue and light: Clinical efficacy and safety profile","volume":"27","author":"Lozano","year":"2013","journal-title":"Transfus Med Rev."},{"key":"10.1016\/j.medcli.2014.09.013_bib0380","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jca.21288","article-title":"The use of 50% albumin\/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura","volume":"28","author":"O\u2019Brien","year":"2013","journal-title":"J Clin Apher."},{"key":"10.1016\/j.medcli.2014.09.013_bib0385","first-page":"774","article-title":"Recuento de plaquetas y volumen plaquetario medio en la poblaci\u00f3n espa\u00f1ola","volume":"110","author":"Lozano","year":"1998","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2014.09.013_bib0390","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1098-1101(1998)13:3<133::AID-JCA7>3.0.CO;2-Z","article-title":"United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): Multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange","volume":"13","author":"Bandarenko","year":"1998","journal-title":"J Clin Apher."},{"key":"10.1016\/j.medcli.2014.09.013_bib0395","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2014.09.013_bib0400","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00277-009-0877-5","article-title":"High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: A randomized study","volume":"89","author":"Balduini","year":"2010","journal-title":"Ann Hematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0405","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07054.x","article-title":"Rituximab in the treatment of autoimmune haematological disorders","volume":"141","author":"Garvey","year":"2008","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0410","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/CCM.0b013e31822e9d66","article-title":"Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center","volume":"40","author":"Froissart","year":"2012","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medcli.2014.09.013_bib0415","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.transci.2010.09.018","article-title":"Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study","volume":"43","author":"de la Rubia","year":"2010","journal-title":"Transfus Apher Sci."},{"key":"10.1016\/j.medcli.2014.09.013_bib0420","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2011-03-341131","article-title":"A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura","volume":"118","author":"Scully","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0425","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1160\/TH07-12-0753","article-title":"Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies","volume":"101","author":"Bresin","year":"2009","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0430","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.thromres.2013.01.024","article-title":"ADAMTS-13 may not predict disease or outcome in patients with thrombotic thrombocytopenic purpura","volume":"131","author":"Rock","year":"2013","journal-title":"Thromb Res."},{"key":"10.1016\/j.medcli.2014.09.013_bib0435","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jth.12114","article-title":"Rituximab for thrombotic thrombocytopenic purpura: Benefit of early administration during acute episodes and use of prophylaxis to prevent relapse","volume":"11","author":"Westwood","year":"2013","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0440","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1538-7836.2010.03818.x","article-title":"Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura","volume":"8","author":"McDonald","year":"2010","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0445","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3324\/haematol.11709","article-title":"Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults","volume":"92","author":"Provan","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2014.09.013_bib0450","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3324\/haematol.12206","article-title":"Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura","volume":"93","author":"Zaja","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2014.09.013_bib0455","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/j.1537-2995.2012.03578.x","article-title":"Splenectomy and\/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: The French TMA Reference Center experience","volume":"52","author":"Beloncle","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.medcli.2014.09.013_bib0460","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1538-7836.2006.01909.x","article-title":"An evaluation of cyclosporine alone for the treatment of early recurrences of thombotic thrombocytopenic purpura","volume":"4","author":"Cataland","year":"2006","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0465","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ajh.21281","article-title":"Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura","volume":"83","author":"Cataland","year":"2008","journal-title":"Am J Hematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0470","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1538-7836.2011.04224.x","article-title":"Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies","volume":"9","author":"Plaimauer","year":"2011","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0475","first-page":"2216","article-title":"Preclinical efficacy testing of Baxter's recombinant ADAMTS13 in a mouse model of TTP","volume":"120","author":"Schiviz","year":"2012","journal-title":"Blood (ASH Annual Meeting Atlanta)"},{"key":"10.1016\/j.medcli.2014.09.013_bib0480","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/jth.12574","article-title":"Effect of recombinant ADAMTS-13 on microthrombosis and brain injury after experimental subarachnoid hemorrhage","volume":"12","author":"Vergouwen","year":"2014","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.medcli.2014.09.013_bib0485","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1172\/JCI46091","article-title":"Thrombotic thrombocytopenic purpura: Reducing the risk","volume":"121","author":"Berndt","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.medcli.2014.09.013_bib0490","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/trf.12440","article-title":"Treatment of refractory thrombotic thrombocytopenic purpura with N-acetylcysteine: A case report","volume":"54","author":"Li","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.medcli.2014.09.013_bib0495","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2012-04-420943","article-title":"Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura","volume":"120","author":"Callewaert","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0500","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1537-2995.2008.02082.x","article-title":"Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura","volume":"49","author":"Swisher","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.medcli.2014.09.013_bib0505","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1098-1101(2000)15:1\/2<53::AID-JCA5>3.0.CO;2-W","article-title":"Therapeutic apheresis in renal and metabolic diseases","volume":"15","author":"Winters","year":"2000","journal-title":"J Clin Apher"},{"key":"10.1016\/j.medcli.2014.09.013_bib0510","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jca.20129","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice: Evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"22","author":"Szczepiorkowski","year":"2007","journal-title":"J Clin Apher."},{"key":"10.1016\/j.medcli.2014.09.013_bib0515","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice--Evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apher."},{"key":"10.1016\/j.medcli.2014.09.013_bib0520","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/ndt\/gfn063","article-title":"Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome","volume":"23","author":"Kwon","year":"2008","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.medcli.2014.09.013_bib0525","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2014.09.013_bib0530","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0535","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"Nurnberger","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2014.09.013_bib0540","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/TP.0b013e3181ccd80d","article-title":"Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation","volume":"89","author":"Fern\u00e1ndez de Larrea","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.medcli.2014.09.013_bib0545","first-page":"1379","article-title":"Eculizumab in atypical hemolytic-uremic syndrome","volume":"369","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2014.09.013_bib0550","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s40265-013-0147-7","article-title":"Eculizumab: A review of its use in atypical haemolytic uraemic syndrome","volume":"73","author":"Keating","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.medcli.2014.09.013_bib0555","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejim.2013.05.008","article-title":"Atypical hemolytic uremic syndrome: From the rediscovery of complement to targeted therapy","volume":"24","author":"Fakhouri","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.medcli.2014.09.013_bib0560","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab","volume":"370","author":"Nishimura","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2014.09.013_bib0565","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molimm.2013.05.224","article-title":"Complement therapy in atypical haemolytic uraemic syndrome (aHUS)","volume":"56","author":"Wong","year":"2013","journal-title":"Mol Immunol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0570","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: Case-control study","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2014.09.013_bib0575","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","article-title":"Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: An analysis of the German STEC-HUS registry","volume":"27","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.medcli.2014.09.013_bib0580","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: Hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0585","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: Real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.medcli.2014.09.013_bib0590","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/bmt.2008.7","article-title":"Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: Defining a disorder","volume":"41","author":"George","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.medcli.2014.09.013_bib0595","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","article-title":"Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Cho","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.medcli.2014.09.013_bib0600","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.09.013_bib0605","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.medcli.2014.09.013_bib0610","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/bjh.12202","article-title":"Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy","volume":"161","author":"Peffault de Latour","year":"2013","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0615","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.2011.08636.x","article-title":"Human immunodeficiency virus associated thrombotic thrombocytopenic purpura--Favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy","volume":"153","author":"Hart","year":"2011","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2014.09.013_bib0620","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4297\/najms.2011.3472.","article-title":"Pseudo-thrombotic thrombocytopenic purpura: A rare presentation of pernicious anemia","volume":"3","author":"Tadakamalla","year":"2011","journal-title":"N Am J Med Sci."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775314007362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775314007362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:43:34Z","timestamp":1717584214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775314007362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":124,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0025775314007362"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2014.09.013","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gu\u00eda diagn\u00f3stica y terap\u00e9utica de las microangiopat\u00edas tromb\u00f3ticas del Grupo Espa\u00f1ol de Af\u00e9resis","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2014.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}